High-dose doxorubicin, etoposide, and cyclophosphamide with stem cell reinfusion in patients with metastatic or high-risk primary breast cancer
Open Access
- 15 March 1994
- Vol. 73 (6) , 1678-1685
- https://doi.org/10.1002/1097-0142(19940315)73:6<1678::aid-cncr2820730621>3.0.co;2-u
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer.Journal of Clinical Oncology, 1993
- The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancerBritish Journal of Cancer, 1989
- Autologous bone marrow transplantation using unfractionated cells cryopreserved in dimethylsulfoxide and hydroxyethyl starch without controlled-rate freezingBlood, 1987
- Adriamycin therapy by continuous intravenous infusion in patients with metastatic breast cancerCancer, 1982
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958